Arkolith/Insider Trading/RAIN/Form 4

Atkisson Erik

General Counsel and CCORain Oncology Inc. (RAIN) · full profile →Form 4 · filed Jan 26, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 26, 2024Disposed to issuer(D)60K——0
Jan 26, 2024Disposed to issuer(D)37K——0
Jan 26, 2024Disposed to issuer(D)83K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001999371-24-000960) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML